Ingevity Corporation NGVT 深 滬
已收盤 04-02 16:00:00 美东时间
71.09
-1.190
-1.65%
華盛通- 最 高72.53
- 今 開70.99
- 成交量 25.02万股
- 最 低 70.37
- 昨 收 72.28
- 總市值 25.04亿
- 52周最高 77.46
- 市盈率 靜 --
- 換手率 0.71%
- 52周最低 30.19
- 委 比 33.33%
- 總股本 3522.25万
- 歷史最高 120.41
- 量 比 0.84
- 振 幅 2.99%
- 歷史最低 22.00
- 每 手 1
- 風險率 11.45%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多BRIEF-Ingevity Corp - Enters Second Amendment And Restatement Agreement On March 26, 2026 - SEC Filing
BRIEF-Ingevity Corp - Enters Second Amendment And Restatement Agreement On March 26, 2026 - SEC Filing March 30 (Reuters) - SEC Filing: INGEVITY CORP - ENTERS SECOND AMENDMENT AND RESTATEMENT AGREEMENT ON MARCH 26, 2026 - SEC FILING INGEVITY CORP - EXTENDS MATURITY DATE OF REVOLVING CREDIT FACILITY
03-30 21:46
Ingevity cuts revolving credit facility to $750 million, extends maturity five years
Ingevity cuts revolving credit facility to $750 million, extends maturity five years Ingevity entered a second amended and restated credit agreement on March 26, 2026, refinancing its revolving credit facility. New revolver maturity extends to five years from closing date. Commitments were cut to US
03-30 18:32
Ingevity imposes temporary surcharge of USD 515/MT on Capa caprolactone products
Ingevity imposes temporary surcharge of USD 515/MT on Capa caprolactone products Ingevity announced a temporary extraordinary surcharge on its Capa caprolactone products due to increased supply chain costs. Effective immediately, the surcharge is USD 515/MT or EUR 440/MT per metric ton on all applic
03-20 21:45
美股大行评级 | 下调居多！多邻国、Elastic、Flutter、欧特克、Zscaler等遭多家机构下调目标价
今日重点评级关注：巴克莱：维持C4 Therapeutics"超配"评级，目标价从5美元升至7美元；富国银行：维持Agilon Health"超配"评级，目标价从1美元升至1.5美元
03-02 14:08
Ingevity Earnings Call Signals Leaner, Higher-Margin Future
Ingevity (($NGVT)) has held its Q4 earnings call. Read on for the main highligh...
03-01 08:13
Wells Fargo Maintains Equal-Weight on Ingevity, Raises Price Target to $75
Wells Fargo analyst Michael Sison maintains Ingevity (NYSE:NGVT) with a Equal-Weight and raises the price target from $65 to $75.
02-28 01:57
Ingevity GAAP EPS of -$2.37, revenue of $278M
Ingevity press release (NGVT): Q4 GAAP EPS of -$2.37. Revenue of $278M (-7.0% Y/Y). More on Ingevity Ingevity Corporation (NGVT) Discusses Strategic Portfolio Update and Leadership Transition Transcri...
02-26 07:00
Ingevity: Q4 Earnings Insights
Ingevity (NYSE:NGVT) reported its Q4 earnings results on Wednesday, February 25...
02-26 05:28
Ingevity Sees FY2026 Sales $1.100B-$1.200B vs $1.224B Est
Ingevity (NYSE:NGVT) sees FY2026 sales of $1.100 billion-$1.200 billion vs $1.224 billion analyst estimate.
02-26 05:28
Earnings Scheduled For February 25, 2026
Companies Reporting Before The Bell • Clear Secure (NYSE:YOU) is expected to re...
02-25 19:11
